Selective inhibition of ANLN may be a new strategy for the treatment of lung cancer47.Solute carrier family 2 member 1 (SLC2A1), also known as glucose transporter 1 (GLUT1), is a glucose transporter coding gene related to the growth and proliferation of tumor cells48. Here, SLC2A1 is linked to neoplasm.